Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers

NCT01766050 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Transplant Rejection

Interventions

DRUG: Caffeine
DRUG: Losartan
DRUG: Omeprazole
DRUG: Dextromethorphan
DRUG: Midazolam
BIOLOGICAL: Belatacept

Sponsor

Bristol-Myers Squibb